Using a dye during head and neck cancer surgery
Treatments studied
Part of Cancer clinical trials.
This study tests whether a special dye (ICG) injected before surgery can help surgeons see head and neck cancer more clearly during the operation. It is for people with squamous cell carcinoma who are at risk of their cancer returning and are scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a type of head and neck cancer called squamous cell carcinoma that comes from the lining of the mouth or throat.
- Your doctor thinks you are at risk for the cancer coming back, and you are healthy enough for surgery.
- If you could become pregnant, you agree to use highly effective birth control during the study.
- You are not pregnant or breastfeeding, and you do not have an allergy to iodides or shellfish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This Phase 2 study tests a special camera and dye during surgery to help surgeons confirm they removed all cancer at the edge of the removed tissue. If it works, it may lower the chance of cancer being left behind after oral cavity or oropharynx squamous cell cancer surgery.
This study compares a special imaging dye (indocyanine green) that helps surgeons see blood flow in reconstructed tissue during head and neck surgery. The goal is to see if using this dye helps surgeons make better decisions about whether the reconstructed tissue will survive and heal properly.
This trial tests two dyes (blue and green) to find hidden lymph nodes during surgery for head or neck cancer. It aims to see if these dyes can better identify which lymph nodes to remove, potentially reducing side effects.
This trial tests whether a special dye helps surgeons see and avoid the nerve that controls the voice box during minimally invasive esophageal cancer surgery. It may reduce the risk of voice problems after surgery.
This trial uses a special dye called ICG that is injected during surgery to help the surgeon see the blood flow to your colon and lymph nodes. It may help make the surgery more precise and improve outcomes for colon cancer.
Hear when a new Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.